Want to see GB:CTG full AI Analyst Report?
Top Page
Christie
(LSE:CTG)
Select Model
Select Model
Rating:67Neutral
Price Target:
187.00 p
▲(15.08% Upside)
Action:Reiterated
Date:08/26/26
The score is primarily driven by improving financial momentum and strong cash flow recovery, tempered by historically volatile profitability and a leveraged balance sheet. Technicals are supportive with the price above key moving averages and positive MACD, while valuation (moderate P/E and a ~2.3% yield) and positive corporate developments provide additional support.
Positive Factors
Revenue and profit recovery
The rebound in revenue and net income indicates renewed demand across Christie’s specialist services and improved operating performance. If sustained, this recovery can strengthen internal funding capacity, support investment in growth, and rebuild resilience after weaker prior years.
Negative Factors
Leveraged balance sheet
Debt materially exceeding equity leaves Christie with less balance-sheet flexibility than a conservatively funded services business. Leverage can constrain investment and distributions, increase sensitivity to earnings setbacks, and make future financing or refinancing more consequential.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and profit recovery
The rebound in revenue and net income indicates renewed demand across Christie’s specialist services and improved operating performance. If sustained, this recovery can strengthen internal funding capacity, support investment in growth, and rebuild resilience after weaker prior years.
Read all positive factors
Christie (CTG) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£42.02M
Dividend Yield2.03%
Average Volume (3M)14.26K
Price to Earnings (P/E)13.7
Beta (1Y)0.39
Revenue Growth16.91%
EPS Growth534.12%
CountryUK
Employees651
SectorIndustrials
Sector Strength72
IndustrySpecialty Business Services
Share Statistics
EPS (TTM)0.13
Shares Outstanding26,526,728
10 Day Avg. Volume15,769
30 Day Avg. Volume14,255
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)5.98
Price to Sales (P/S)0.45
P/FCF Ratio4.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.14
Revenue Forecast (FY)£75.00M
Christie Business Overview & Revenue Model
Company Description
Christie Group plc is a well-established provider of professional services, operating across Europe and internationally. The company serves a diverse range of industries including hospitality, leisure, healthcare, medical, childcare, education, an...
Christie Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
48
Neutral
Cash Flow
70
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 70.60M | 60.39M | 52.34M | 69.19M | 61.25M |
| Gross Profit | 70.60M | 2.00M | 14.77M | 5.22M | 2.58M |
| EBITDA | 8.83M | 3.94M | -1.25M | 7.25M | 6.94M |
| Net Income | 3.40M | 536.00K | -3.80M | 3.21M | 3.58M |
Balance Sheet | |||||
| Total Assets | 34.38M | 29.51M | 29.45M | 36.44M | 36.94M |
| Cash, Cash Equivalents and Short-Term Investments | 9.40M | 4.87M | 1.34M | 8.84M | 8.17M |
| Total Debt | 9.48M | 8.71M | 10.34M | 11.65M | 12.23M |
| Total Liabilities | 29.02M | 24.40M | 26.15M | 28.04M | 35.38M |
| Stockholders Equity | 5.36M | 5.11M | 3.30M | 8.40M | 1.56M |
Cash Flow | |||||
| Free Cash Flow | 6.96M | 2.23M | -4.38M | 4.39M | 1.80M |
| Operating Cash Flow | 7.47M | 2.73M | -3.46M | 5.18M | 2.34M |
| Investing Cash Flow | -1.24M | 2.55M | -797.00K | -787.00K | -487.00K |
| Financing Cash Flow | -1.70M | -1.66M | -3.32M | -3.71M | -3.21M |
Christie Technical Analysis
Positive
162.50
Price Trends
148.17
Positive
144.20
Positive
134.25
Positive
Market Momentum
4.81
Negative
87.69
Negative
75.37
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:CTG, the sentiment is Positive. The current price of 162.5 is above the 20-day moving average (MA) of 156.33, above the 50-day MA of 148.17, and above the 200-day MA of 134.25, indicating a bullish trend. The MACD of 4.81 indicates Negative momentum. The RSI at 87.69 is Negative, neither overbought nor oversold. The STOCH value of 75.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:CTG.
Christie Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £8.59B | 24.22 | 5.82% | 2.75% | -0.18% | 39.04% | |
72 Outperform | £2.65B | 32.48 | 15.86% | 2.14% | 10.55% | -19.05% | |
68 Neutral | £8.98B | 28.13 | 29.86% | 2.82% | 3.94% | -8.14% | |
68 Neutral | £2.44B | 16.41 | 17.55% | 1.84% | 1.20% | 221.80% | |
67 Neutral | £42.02M | 13.66 | 66.04% | 2.03% | 16.91% | 534.12% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
* Industrials Sector Average
GB:CTG
Christie
172.50
58.00
50.65%
GB:ITRK
Intertek
5,850.00
1,296.51
28.47%
GB:MTO
Mitie Group plc
209.80
73.81
54.27%
GB:RTO
Rentokil Initial
341.70
-28.83
-7.78%
GB:SRP
Serco Group plc
252.20
35.19
16.22%
Christie Corporate Events
Business Operations and Strategy
Christie Group Highlights Strengthening UK Dental Market in 2026 Review
Positive
Sep 8, 2026
Christie Group’s agency and advisory arm, Christie Co, has released its Dental Market Review 2026, offering a detailed assessment of the UK dental sector based on transactional data, sentiment surveys and advisory work, alongside lending an...
Business Operations and StrategyExecutive/Board Changes
Christie Group Adds Christie & Co Chief Darren Bond to Board
Positive
Sep 7, 2026
Christie Group plc has strengthened its board with the appointment of Darren Bond, Global Managing Director of Christie Co, as an Executive Director with immediate effect. Bond brings extensive experience in valuation, brokerage, consultancy and ...
Business Operations and Strategy
Christie & Co expands market-leading dental brokerage into Republic of Ireland
Positive
Aug 4, 2026
Christie Group’s agency and advisory arm, Christie Co, has launched a dedicated dental brokerage service in the Republic of Ireland, extending its UK-leading dental advisory operation into a new European market. The move brings its speciali...
Business Operations and Strategy
Christie Group Highlights Strong Deal Activity in UK Day Nurseries with 2026 Market Review
Positive
Jul 13, 2026
Christie Group’s agency and advisory arm, Christie Co, has released its Day Nurseries Market Review 2026, offering a detailed assessment of the UK children’s day nurseries sector, including occupancy trends, fee growth, margins, inves...
Business Operations and Strategy
Christie & Co flags stabilising UK hotel market in 2026 review
Positive
Jun 25, 2026
Christie Group’s agency and advisory arm, Christie Co, has released its UK Hotel Market Review 2026, highlighting a stabilising hotel sector where resilient demand meets shifting traveller behaviour and evolving tourism flows. The report ex...
Business Operations and StrategyShareholder Meetings
Christie Group Wins Strong AGM Backing as One Special Resolution Falls Short
Positive
Jun 17, 2026
Christie Group plc reported that seven of the eight resolutions proposed at its 16 June 2026 Annual General Meeting were approved by shareholders, including six ordinary resolutions and one special resolution. A seventh resolution, requiring speci...
Shareholder Meetings
Christie Group Secures Majority of AGM Resolutions as One Special Measure Falls Short
Neutral
Jun 17, 2026
Christie Group plc, the AIM-listed provider of professional and financial services alongside stock and inventory systems for specialist consumer sectors, confirmed the voting outcomes of its Annual General Meeting held on 16 June 2026. The group, ...
Business Operations and StrategyFinancial Disclosures
Christie Group Sees Strong Start to 2026, Keeps Full-Year Outlook Intact
Positive
Jun 16, 2026
Christie Group reported a strong start to 2026, with robust demand across its specialist sectors, resilient lender and investor appetite, and a UK agency pipeline up more than 14% in value and 19% in deal volumes year on year. Valuation and busine...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.